Korro Bio (KRRO) Shares Outstanding (Diluted) (2022 - 2026)
Korro Bio (KRRO) reported Shares Outstanding (Diluted) of 17.62 million for Q2 2026, up 87.6% from 9.39 million a year earlier and up 51.9% from the prior quarter.
Powered by 
Analysis
Korro Bio (KRRO) Shares Outstanding (Diluted) (2022 - 2026) Analysis & Trends
For FY2025, Korro Bio posted Shares Outstanding (Diluted) of 9.4 million, up 5.3% from FY2024.
- Shares Outstanding (Diluted) has increased for three consecutive years, with a three-year compound annual growth rate of 232.7% (FY2022 to FY2025).
- By year, Shares Outstanding (Diluted) came in at 8.92 million in FY2024 (+483.3%), 1.53 million in FY2023 (+499.3%) and 255,175 in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Shares Outstanding (Diluted) since Q3 2023.
- Year over year, Shares Outstanding (Diluted) has now increased in each of the last seven quarters, with growth averaging 68.4% over the last eight quarters.
- The high point for year-over-year Shares Outstanding (Diluted) in five years was Q4 2023 (growth of 499.3%); the low point was Q3 2024 (a decline of 74.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 11.6 million (Q1 2026), 9.4 million (Q4 2025) and 9.39 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Korro Bio | 145.73 Mn | -250.91 Mn | - | 17.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.62 Mn |
| Mar 31, 2026 | 11.60 Mn |
| Dec 31, 2025 | 9.40 Mn |
| Sep 30, 2025 | 9.39 Mn |
| Jun 30, 2025 | 9.39 Mn |
| Mar 31, 2025 | 9.38 Mn |
| Dec 31, 2024 | 8.92 Mn |
| Sep 30, 2024 | 9.30 Mn |
| Jun 30, 2024 | 8.99 Mn |
| Mar 31, 2024 | 8.02 Mn |
| Dec 31, 2023 | 1.53 Mn |
| Sep 30, 2023 | 36.92 Mn |
| Jun 30, 2023 | 276,482.00 |
| Mar 31, 2023 | 271,522.00 |
| Dec 31, 2022 | 255,175.00 |
| Sep 30, 2022 | 35.25 Mn |
API Access
Korro Bio Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=KRRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "KRRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=KRRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();